USD 34.16
(4.62%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 | 14.2 Million USD | -11.6% |
2023 | 16.07 Million USD | 58.59% |
2022 | 10.13 Million USD | -28.61% |
2021 | 14.19 Million USD | 14.62% |
2020 | 12.38 Million USD | 64.81% |
2019 | 7.51 Million USD | -33.82% |
2018 | 11.35 Million USD | -10.63% |
2017 | 12.7 Million USD | 139.29% |
2016 | 5.31 Million USD | -32.02% |
2015 | 7.81 Million USD | 40.87% |
2014 | 5.54 Million USD | 204.58% |
2013 | 1.82 Million USD | -17.4% |
2012 | 2.2 Million USD | 20.41% |
2011 | 1.83 Million USD | 13.39% |
2010 | 1.61 Million USD | -6.79% |
2009 | 1.73 Million USD | 5.74% |
2008 | 1.63 Million USD | 33.1% |
2007 | 1.23 Million USD | 45.68% |
2006 | 844.89 Thousand USD | 20.92% |
2005 | 698.7 Thousand USD | 34.89% |
2004 | 517.97 Thousand USD | -24.76% |
2003 | 688.46 Thousand USD | -15.85% |
2002 | 818.1 Thousand USD | -16.03% |
2001 | 974.29 Thousand USD | -0.56% |
2000 | 979.77 Thousand USD | 12.54% |
1999 | 870.59 Thousand USD | 19.74% |
1998 | 727.06 Thousand USD | 71.2% |
1997 | 424.69 Thousand USD | -46.91% |
1996 | 800 Thousand USD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q3 | 11.83 Million USD | -30.13% |
2024 Q4 | 14.2 Million USD | 20.08% |
2024 Q1 | 13.43 Million USD | -16.39% |
2024 Q2 | 16.93 Million USD | 26.03% |
2023 Q3 | 9.74 Million USD | 13.2% |
2023 Q2 | 8.6 Million USD | -16.74% |
2023 Q1 | 10.33 Million USD | 2.02% |
2023 FY | 16.07 Million USD | 58.59% |
2023 Q4 | 16.07 Million USD | 64.94% |
2022 FY | 10.13 Million USD | -28.61% |
2022 Q3 | 8.66 Million USD | -30.51% |
2022 Q2 | 12.46 Million USD | -0.56% |
2022 Q4 | 10.13 Million USD | 16.97% |
2022 Q1 | 12.53 Million USD | -11.68% |
2021 Q2 | 14.27 Million USD | 14.74% |
2021 FY | 14.19 Million USD | 14.62% |
2021 Q1 | 12.43 Million USD | 0.43% |
2021 Q4 | 14.19 Million USD | 3.73% |
2021 Q3 | 13.68 Million USD | -4.11% |
2020 Q3 | 14.99 Million USD | 79.81% |
2020 FY | 12.38 Million USD | 64.81% |
2020 Q1 | 8.57 Million USD | 14.13% |
2020 Q2 | 8.33 Million USD | -2.79% |
2020 Q4 | 12.38 Million USD | -17.39% |
2019 Q4 | 7.51 Million USD | -21.17% |
2019 Q1 | 9.62 Million USD | -15.24% |
2019 Q2 | 9.6 Million USD | -0.18% |
2019 Q3 | 9.53 Million USD | -0.78% |
2019 FY | 7.51 Million USD | -33.82% |
2018 Q4 | 11.35 Million USD | -3.52% |
2018 FY | 11.35 Million USD | -10.63% |
2018 Q3 | 11.77 Million USD | 1.21% |
2018 Q2 | 11.63 Million USD | -11.02% |
2018 Q1 | 13.07 Million USD | 2.87% |
2017 Q2 | 4.89 Million USD | -4.91% |
2017 Q1 | 5.14 Million USD | -3.04% |
2017 FY | 12.7 Million USD | 139.29% |
2017 Q4 | 12.7 Million USD | 193.99% |
2017 Q3 | 4.32 Million USD | -11.72% |
2016 Q3 | 7.29 Million USD | -3.94% |
2016 Q1 | 8.02 Million USD | 2.71% |
2016 FY | 5.31 Million USD | -32.02% |
2016 Q2 | 7.59 Million USD | -5.39% |
2016 Q4 | 5.31 Million USD | -27.18% |
2015 Q1 | 8.64 Million USD | 55.85% |
2015 Q3 | 8.09 Million USD | -3.4% |
2015 Q4 | 7.81 Million USD | -3.5% |
2015 Q2 | 8.38 Million USD | -3.04% |
2015 FY | 7.81 Million USD | 40.87% |
2014 Q1 | 2.05 Million USD | 12.85% |
2014 FY | 5.54 Million USD | 204.58% |
2014 Q4 | 5.54 Million USD | -6.54% |
2014 Q3 | 5.93 Million USD | 158.68% |
2014 Q2 | 2.29 Million USD | 11.65% |
2013 Q4 | 1.82 Million USD | -6.21% |
2013 FY | 1.82 Million USD | -17.4% |
2013 Q1 | 1.55 Million USD | -29.3% |
2013 Q2 | 1.72 Million USD | 10.42% |
2013 Q3 | 1.94 Million USD | 12.81% |
2012 Q3 | 2.8 Million USD | -15.21% |
2012 FY | 2.2 Million USD | 20.41% |
2012 Q4 | 2.2 Million USD | -21.51% |
2012 Q2 | 3.31 Million USD | 76.95% |
2012 Q1 | 1.87 Million USD | 2.25% |
2011 Q2 | 2.12 Million USD | 34.69% |
2011 Q3 | 2.52 Million USD | 18.76% |
2011 Q4 | 1.83 Million USD | -27.62% |
2011 Q1 | 1.58 Million USD | -2.06% |
2011 FY | 1.83 Million USD | 13.39% |
2010 Q1 | 2.01 Million USD | 16.43% |
2010 Q4 | 1.61 Million USD | -9.03% |
2010 Q3 | 1.77 Million USD | -17.51% |
2010 Q2 | 2.15 Million USD | 6.68% |
2010 FY | 1.61 Million USD | -6.79% |
2009 Q1 | 1.79 Million USD | 9.47% |
2009 Q2 | 2.17 Million USD | 21.4% |
2009 Q4 | 1.73 Million USD | -5.8% |
2009 FY | 1.73 Million USD | 5.74% |
2009 Q3 | 1.83 Million USD | -15.53% |
2008 Q2 | 1.09 Million USD | -3.9% |
2008 Q3 | 1.66 Million USD | 52.04% |
2008 Q4 | 1.63 Million USD | -1.57% |
2008 FY | 1.63 Million USD | 33.1% |
2008 Q1 | 1.13 Million USD | -7.45% |
2007 Q3 | 936 Thousand USD | -10.57% |
2007 Q1 | 779.06 Thousand USD | -7.79% |
2007 FY | 1.23 Million USD | 45.68% |
2007 Q4 | 1.23 Million USD | 31.5% |
2007 Q2 | 1.04 Million USD | 34.35% |
2006 FY | 844.89 Thousand USD | 20.92% |
2006 Q3 | 632.59 Thousand USD | 16.06% |
2006 Q2 | 545.08 Thousand USD | -15.86% |
2006 Q1 | 647.8 Thousand USD | -7.28% |
2006 Q4 | 844.89 Thousand USD | 33.56% |
2005 FY | 698.7 Thousand USD | 34.89% |
2005 Q1 | 514.59 Thousand USD | -0.65% |
2005 Q4 | 698.7 Thousand USD | 35.79% |
2005 Q3 | 514.53 Thousand USD | 7.05% |
2005 Q2 | 480.63 Thousand USD | -6.6% |
2004 FY | 517.97 Thousand USD | -24.76% |
2004 Q4 | 517.97 Thousand USD | -2.79% |
2004 Q3 | 532.84 Thousand USD | 3.13% |
2004 Q2 | 516.65 Thousand USD | -5.24% |
2004 Q1 | 545.25 Thousand USD | -20.8% |
2003 Q2 | 539.92 Thousand USD | -22.07% |
2003 Q1 | 692.86 Thousand USD | -15.31% |
2003 FY | 688.46 Thousand USD | -15.85% |
2003 Q4 | 688.46 Thousand USD | 58.29% |
2003 Q3 | 434.93 Thousand USD | -19.45% |
2002 Q3 | 724.97 Thousand USD | -22.41% |
2002 Q4 | 818.1 Thousand USD | 12.85% |
2002 FY | 818.1 Thousand USD | -16.03% |
2002 Q1 | 1.02 Million USD | 5.1% |
2002 Q2 | 934.31 Thousand USD | -8.75% |
2001 Q4 | 974.29 Thousand USD | 3.64% |
2001 FY | 974.29 Thousand USD | -0.56% |
2001 Q1 | 988.61 Thousand USD | 0.9% |
2001 Q2 | 992.58 Thousand USD | 0.4% |
2001 Q3 | 940.03 Thousand USD | -5.29% |
2000 Q4 | 979.77 Thousand USD | 14.18% |
2000 Q1 | 864.13 Thousand USD | -0.74% |
2000 Q2 | 769.88 Thousand USD | -10.91% |
2000 Q3 | 858.09 Thousand USD | 11.46% |
2000 FY | 979.77 Thousand USD | 12.54% |
1999 Q2 | 700 Thousand USD | 0.0% |
1999 FY | 870.59 Thousand USD | 19.74% |
1999 Q3 | 700 Thousand USD | 0.0% |
1999 Q1 | 700 Thousand USD | -3.72% |
1999 Q4 | 870.59 Thousand USD | 24.37% |
1998 Q1 | 400 Thousand USD | -5.81% |
1998 Q2 | 300 Thousand USD | -25.0% |
1998 FY | 727.06 Thousand USD | 71.2% |
1998 Q3 | 600 Thousand USD | 100.0% |
1998 Q4 | 727.06 Thousand USD | 21.18% |
1997 Q4 | 424.69 Thousand USD | -83.01% |
1997 Q2 | 2.2 Million USD | 0.0% |
1997 FY | 424.69 Thousand USD | -46.91% |
1997 Q3 | 2.5 Million USD | 13.64% |
1996 FY | 800 Thousand USD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Augmedix, Inc. | 43.39 Million USD | 67.256% |
OneMedNet Corporation | 13.32 Million USD | -6.645% |
Minerva Surgical, Inc. | 51.71 Million USD | 72.528% |
CareCloud, Inc. | 37.79 Million USD | 62.41% |
CareCloud, Inc. | 37.79 Million USD | 62.41% |
HealthEquity, Inc. | 1.2 Billion USD | 98.817% |
iCoreConnect Inc. | 11.24 Million USD | -26.379% |
Progyny, Inc. | 203.19 Million USD | 93.008% |
Renalytix Plc | 15.82 Million USD | 10.224% |
Schrödinger, Inc. | 254.39 Million USD | 94.415% |
SOPHiA GENETICS SA | 54.71 Million USD | 74.032% |
Omnicell, Inc. | 1.03 Billion USD | 98.631% |
BrightSpring Health Services, Inc. Common Stock | 5.17 Billion USD | 99.726% |
Streamline Health Solutions, Inc. | 22.92 Million USD | 38.027% |
Inovalon Holdings, Inc. | 1.26 Billion USD | 98.875% |
Ontrak, Inc. | 5.57 Million USD | -154.852% |
Nutex Health, Inc. | 319.13 Million USD | 95.548% |
GE HealthCare Technologies Inc. | 25.14 Billion USD | 99.943% |
Sharecare, Inc. | 125.56 Million USD | 88.685% |
Aclarion, Inc. | 3.18 Million USD | -345.704% |
CareMax, Inc. | 561.85 Million USD | 97.471% |
Bullfrog AI Holdings, Inc. Common Stock | 184.35 Thousand USD | -7607.079% |
Forian Inc. | 33.19 Million USD | 57.2% |
Bullfrog AI Holdings, Inc. Warrants | 184.35 Thousand USD | -7607.079% |
HeartBeam, Inc. | 1.19 Million USD | -1089.95% |
GeneDx Holdings Corp. | 245.65 Million USD | 94.216% |
SCWorx Corp. | 2.42 Million USD | -485.953% |
Definitive Healthcare Corp. | 626.72 Million USD | 97.733% |
10x Genomics, Inc. | 224.1 Million USD | 93.66% |
Zhongchao Inc. | 3.37 Million USD | -320.545% |
Accolade, Inc. | 342.68 Million USD | 95.854% |
MSP Recovery, Inc. | 1.74 Billion USD | 99.184% |
R1 RCM Inc. | 2.2 Billion USD | 99.357% |
Spok Holdings, Inc. | 63.91 Million USD | 77.77% |
Privia Health Group, Inc. | 392.51 Million USD | 96.38% |
EUDA Health Holdings Limited | 8.79 Million USD | -61.593% |
TruBridge, Inc. | 247.8 Million USD | 94.266% |
BrightSpring Health Services, Inc. Tangible Equity Unit | 5.17 Billion USD | 99.726% |
Sharecare, Inc. | 125.56 Million USD | 88.685% |
Health Catalyst, Inc. | 334.89 Million USD | 95.757% |
GoodRx Holdings, Inc. | 826.84 Million USD | 98.282% |
Premier, Inc. | 1.46 Billion USD | 99.031% |
HealthStream, Inc. | 159.19 Million USD | 91.075% |
Certara, Inc. | 516.29 Million USD | 97.248% |
GeneDx Holdings Corp. | 245.65 Million USD | 94.216% |
Ontrak, Inc. | 5.57 Million USD | -154.852% |
SHL Telemedicine Ltd. | 36.58 Million USD | 61.168% |
CareCloud, Inc. | 37.79 Million USD | 62.41% |
EUDA Health Holdings Limited | 8.79 Million USD | -61.593% |
HeartBeam, Inc. | 1.19 Million USD | -1089.95% |
Mangoceuticals, Inc. | 276.03 Thousand USD | -5047.099% |
CareMax, Inc. | 561.85 Million USD | 97.471% |
Healthcare Triangle, Inc. | 9.51 Million USD | -49.385% |
National Research Corporation | 73.48 Million USD | 80.665% |
Aclarion, Inc. | 3.18 Million USD | -345.704% |
OptimizeRx Corporation | 56.82 Million USD | 74.995% |